25 January 2019 : Letter/Correspondence
Good Results with Individually Adapted Long-Term Immunosuppression Following Alemtuzumab Versus ATG Induction Therapy in Combined Kidney-Pancreas Transplantation: A Single-Center Report
DOI: 10.12659/AOT.911712
Ann Transplant 2019; 24:52-56
HTML version available soon